Clinical trial
Role of Percutaneous Transluminal Angioplasty for Wound Healing and Dynamics of the Microbial Community in Patients With Type 2 Diabetes and Diabetic Foot Syndrome
NCT06124586 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Percutaneous Transluminal Angioplasty for Wound Healing and Dynamics of the Microbial Community in Patients With Type 2 Diabetes and Diabetic Foot Syndrome
- Lead sponsor
- Heinrich-Heine University, Duesseldorf
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 1, 2024
- Completion date
- November 1, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, diabetes mellitus, diabetic foot, diabetic neuropathies, diabetic polyneuropathy, diabetic retinopathy, peripheral arterial disease, ulcer foot, ulcer ischemic